NO171160C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-hydroksyetyl)-2-oksetanonderivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-hydroksyetyl)-2-oksetanonderivaterInfo
- Publication number
- NO171160C NO171160C NO855213A NO855213A NO171160C NO 171160 C NO171160 C NO 171160C NO 855213 A NO855213 A NO 855213A NO 855213 A NO855213 A NO 855213A NO 171160 C NO171160 C NO 171160C
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- opt
- ring
- oxetanode
- hydroxyethyl
- Prior art date
Links
- -1 2-HYDROXYETHYL Chemical class 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 2
- 101100134927 Gallus gallus COR8 gene Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH610284 | 1984-12-21 | ||
| CH393485 | 1985-09-12 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO855213L NO855213L (no) | 1986-06-23 |
| NO171160B NO171160B (no) | 1992-10-26 |
| NO171160C true NO171160C (no) | 1993-02-03 |
Family
ID=25694219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO855213A NO171160C (no) | 1984-12-21 | 1985-12-20 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-hydroksyetyl)-2-oksetanonderivater |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US4931463A (cs) |
| EP (1) | EP0185359B1 (cs) |
| CN (1) | CN1012643B (cs) |
| AT (1) | ATE70061T1 (cs) |
| AU (1) | AU583569B2 (cs) |
| CA (1) | CA1270837A (cs) |
| CS (1) | CS262425B2 (cs) |
| DE (1) | DE3584829D1 (cs) |
| DK (1) | DK166724B1 (cs) |
| DO (1) | DOP1985004386A (cs) |
| FI (1) | FI91403C (cs) |
| HU (1) | HU200172B (cs) |
| IE (1) | IE58926B1 (cs) |
| IL (1) | IL77338A (cs) |
| MC (1) | MC1728A1 (cs) |
| NO (1) | NO171160C (cs) |
| NZ (1) | NZ214565A (cs) |
| PH (1) | PH26291A (cs) |
| PT (1) | PT81748B (cs) |
| ZW (1) | ZW20385A1 (cs) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5246960A (en) * | 1984-12-21 | 1993-09-21 | Hoffmann-La Roche Inc. | Oxetanones |
| CA1328881C (en) * | 1984-12-21 | 1994-04-26 | Pierre Barbier | Process for the manufacture of oxetanones |
| US4895973A (en) * | 1986-08-14 | 1990-01-23 | G. D. Searle & Company | Substituted glutaric acid lactones in the treatment of hyperlipidemia |
| US4806564A (en) * | 1987-05-26 | 1989-02-21 | Merck & Co., Inc. | Antihypercholesterolemic beta-lactones |
| US4816477A (en) * | 1987-05-26 | 1989-03-28 | Merck & Co., Inc. | Antihypercholesterolemic β-lactones |
| CA2035972C (en) * | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
| US5260310A (en) * | 1990-02-26 | 1993-11-09 | Hoffmann-La Roche Inc. | Oxetanone compounds and pharmaceutical compositions containing them |
| CA2098167C (en) * | 1992-06-24 | 2006-12-19 | Dorothea Isler | Foodstuffs and feedstuffs containing a lipase inhibitor |
| NZ336755A (en) * | 1997-02-05 | 2001-06-29 | F | Use of gastrointestinal lipase inhibitors in particular tetrahydrolipstatin (orlistat) |
| KR100510614B1 (ko) * | 1997-04-15 | 2005-08-30 | 씨에스아이알 | 식욕 억제 활성을 갖는 화합물의 제조를 위한 중간체 및이의 제조 방법 |
| GB2396815B (en) * | 1999-10-27 | 2004-09-08 | Phytopharm Plc | A composition comprising a pregnenone derivative and an NSAID |
| CA2358921A1 (en) * | 1999-10-29 | 2001-05-10 | John Jason Gentry Mullins | Oxetanone derivatives |
| EP1132389A1 (en) | 2000-03-06 | 2001-09-12 | Vernalis Research Limited | New aza-indolyl derivatives for the treatment of obesity |
| GB2363985B (en) * | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
| JP4772264B2 (ja) * | 2000-07-28 | 2011-09-14 | エフ．ホフマン−ラ ロシュ アーゲー | リパーゼ阻害物質の新規用途 |
| AU2002212120B2 (en) | 2000-08-09 | 2006-05-11 | Cheplapharm Arzneimittel Gmbh | Lipase inhibitors for the treatment of dyspepsia |
| US6900226B2 (en) | 2000-09-06 | 2005-05-31 | Hoffman-La Roche Inc. | Neuropeptide Y antagonists |
| US6392061B1 (en) * | 2000-10-16 | 2002-05-21 | Zpro Chemical, Inc. | Process for making (2S, 3S, 5S) oxetanone derivatives |
| CA2422698C (en) | 2000-10-16 | 2009-12-15 | F. Hoffmann-La Roche Ag | Indoline derivatives and their use as 5-ht2 receptor ligands |
| GB0030710D0 (en) | 2000-12-15 | 2001-01-31 | Hoffmann La Roche | Piperazine derivatives |
| KR100539143B1 (ko) | 2000-12-27 | 2005-12-26 | 에프. 호프만-라 로슈 아게 | 인돌 유도체 및 그의 5-ｈｔ2ｂ 및 5-ｈｔ2ｃ 수용체리간드로서의 용도 |
| GB0106177D0 (en) | 2001-03-13 | 2001-05-02 | Hoffmann La Roche | Piperazine derivatives |
| DE60225274T2 (de) | 2001-05-21 | 2009-03-26 | F. Hoffmann-La Roche Ag | Chinolinderivate als liganden für den neuropeptid-y-rezeptor |
| US6730319B2 (en) | 2001-06-06 | 2004-05-04 | Hoffmann-La Roche Inc. | Pharmaceutical compositions having depressed melting points |
| US20030027786A1 (en) | 2001-06-06 | 2003-02-06 | Karsten Maeder | Lipase inhibiting composition |
| US6787558B2 (en) | 2001-09-28 | 2004-09-07 | Hoffmann-La Roche Inc. | Quinoline derivatives |
| GB0202015D0 (en) | 2002-01-29 | 2002-03-13 | Hoffmann La Roche | Piperazine Derivatives |
| CN100383124C (zh) | 2002-02-04 | 2008-04-23 | 霍夫曼-拉罗奇有限公司 | 作为npy拮抗剂的喹啉衍生物 |
| RU2004129285A (ru) | 2002-02-28 | 2005-10-27 | Ф.Хоффманн-Ля Рош Аг (Ch) | Производные тиазола в качестве антагонистов рецептора npy |
| US7728153B2 (en) | 2002-04-17 | 2010-06-01 | The Burnham Institute For Medical Research | Method for the asymmetric synthesis of beta-lactone compounds |
| WO2003088975A1 (en) * | 2002-04-17 | 2003-10-30 | The Burnham Institute | Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation |
| RU2296757C2 (ru) | 2002-07-05 | 2007-04-10 | Ф.Хоффманн-Ля Рош Аг | Производные хиназолина |
| CN100381429C (zh) | 2002-08-07 | 2008-04-16 | 霍夫曼-拉罗奇有限公司 | 噻唑衍生物 |
| RU2296759C2 (ru) | 2002-09-12 | 2007-04-10 | Ф.Хоффманн-Ля Рош Аг | N-замещенные 1н-индол-5-пропионовые кислоты, фармацевтическая композиция, содержащая эти соединения, и их применение (варианты) |
| US6727277B1 (en) | 2002-11-12 | 2004-04-27 | Kansas State University Research Foundation | Compounds affecting cholesterol absorption |
| ES2312819T3 (es) | 2002-11-25 | 2009-03-01 | F. Hoffmann-La Roche Ag | Derivados de indolilo. |
| GB0314967D0 (en) | 2003-06-26 | 2003-07-30 | Hoffmann La Roche | Piperazine derivatives |
| WO2005005403A2 (en) * | 2003-07-15 | 2005-01-20 | Ranbaxy Laboratories Limited | Process for preparation of oxetan-2-ones |
| CA2533464A1 (en) | 2003-08-12 | 2005-02-17 | F. Hoffmann-La Roche Ag | Thiazole derivatives as npy antagonists |
| CN100422179C (zh) | 2003-08-12 | 2008-10-01 | 霍夫曼-拉罗奇有限公司 | 2-氨基-5-苯甲酰基噻唑npy拮抗剂 |
| US7074822B2 (en) * | 2004-02-23 | 2006-07-11 | Solvay Pharmaceuticals Gmbh | Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them |
| DE102004009076A1 (de) * | 2004-02-23 | 2005-10-27 | Solvay Pharmaceuticals Gmbh | Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US7121355B2 (en) * | 2004-09-21 | 2006-10-17 | Cnh America Llc | Bulldozer autograding system |
| WO2006035296A1 (en) * | 2004-09-27 | 2006-04-06 | Ranbaxy Laboratories Limited | Process for the preparation of an orlistat derivative useful as reference standard in the determination of the purity of orlistat and process for the preparation of orlistat |
| JP2008540368A (ja) | 2005-05-03 | 2008-11-20 | エフ．ホフマン−ラ ロシュ アーゲー | ５−ｈｔ２リガンドとしての四環式アザピラジノインドリン |
| ATE430744T1 (de) | 2005-08-18 | 2009-05-15 | Hoffmann La Roche | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren |
| US20090171104A1 (en) * | 2005-10-05 | 2009-07-02 | Killol Patel | Process for the preparation of orlistat |
| BRPI0619266A2 (pt) | 2005-11-30 | 2011-09-27 | Hoffmann La Roche | compostos, processo para a sua manufatura, composições farmacêuticas, métodos para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3, obesidade, diabetes do tipo ii e seu uso |
| KR101124156B1 (ko) | 2005-11-30 | 2012-03-23 | 에프. 호프만-라 로슈 아게 | 1,5-치환된 인돌-2-일 아마이드 유도체 |
| CA2630270A1 (en) | 2005-11-30 | 2007-06-07 | F. Hoffmann-La Roche Ag | 5-substituted indole-2-carboxamide derivatives |
| AU2006324089A1 (en) | 2005-12-09 | 2007-06-14 | F. Hoffmann-La Roche Ag | Tricyclic amide derivatives useful for treating obesity |
| KR20080068127A (ko) | 2005-12-15 | 2008-07-22 | 에프. 호프만-라 로슈 아게 | 피롤로[2,3-ｃ]피리딘 유도체 |
| CN101331131A (zh) | 2005-12-16 | 2008-12-24 | 霍夫曼-拉罗奇有限公司 | 用作H3受体调节剂的吡咯并[2,3-b]吡啶衍生物 |
| JP2009523150A (ja) * | 2006-01-13 | 2009-06-18 | エフ．ホフマン−ラ ロシュ アーゲー | シクロヘキシルピペラジニルメタノン誘導体及びｈ３受容体調節剤としてのそれらの使用 |
| CN101370779B (zh) * | 2006-01-23 | 2011-07-20 | 霍夫曼-拉罗奇有限公司 | 具有h3受体活性的环己基磺酰胺衍生物 |
| US7432255B2 (en) | 2006-05-16 | 2008-10-07 | Hoffmann-La Roche Inc. | 1H-indol-5-yl-piperazin-1-yl-methanone derivatives |
| CN101448820A (zh) * | 2006-05-30 | 2009-06-03 | 霍夫曼-拉罗奇有限公司 | 哌啶基嘧啶衍生物 |
| US7514433B2 (en) | 2006-08-03 | 2009-04-07 | Hoffmann-La Roche Inc. | 1H-indole-6-yl-piperazin-1-yl-methanone derivatives |
| US20080146559A1 (en) | 2006-12-08 | 2008-06-19 | Li Chen | 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives |
| WO2008149321A2 (en) * | 2007-06-06 | 2008-12-11 | Ranbaxy Laboratories Limited | Process for the preparation of orlistat |
| CN101796043A (zh) | 2007-07-25 | 2010-08-04 | 霍夫曼-拉罗奇有限公司 | 苯并呋喃-和苯并[b]噻吩-2-羧酸酰胺衍生物及其作为阻胺3受体调节剂的应用 |
| JP2011502167A (ja) * | 2007-10-31 | 2011-01-20 | バーンハム インスティテュート フォー メディカル リサーチ | β−ラクトン化合物 |
| US8993509B2 (en) | 2009-03-31 | 2015-03-31 | Robert Zimmerman | Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity |
| WO2010112569A1 (en) | 2009-03-31 | 2010-10-07 | Robert Zimmermann | Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor |
| WO2011140296A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals | Triazoles as inhibitors of fatty acid synthase |
| CA2798330A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals, Inc. | Tetrazolones as inhibitors of fatty acid synthase |
| SG11202000239XA (en) | 2017-07-12 | 2020-02-27 | Mayo Found Medical Education & Res | Compounds for the reducing lipotoxic damage |
| CN112079821A (zh) * | 2020-09-14 | 2020-12-15 | 中山万汉制药有限公司 | 奥利司他与苯氨基嘧啶类化合物形成的缀合物及其制备方法与用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2478388A (en) * | 1945-09-28 | 1949-08-09 | Eastman Kodak Co | beta-lactones from unsaturated aldehydes and unsaturated ketones |
| JPS608117B2 (ja) * | 1977-02-08 | 1985-02-28 | 財団法人微生物化学研究会 | 新生理活性物質エステラスチンおよびその製造法 |
| GB2023604B (en) * | 1978-05-25 | 1982-07-28 | Microbial Chem Res Found | Physiologically active derivatives of esterastin and production thereof |
| JPS56128774A (en) * | 1980-03-14 | 1981-10-08 | Microbial Chem Res Found | New physiologically active substance ebelactone and its preparation |
| CA1247547A (en) * | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
-
1985
- 1985-11-12 CA CA000495058A patent/CA1270837A/en not_active Expired - Lifetime
- 1985-11-15 ZW ZW203/85A patent/ZW20385A1/xx unknown
- 1985-12-04 FI FI854797A patent/FI91403C/fi not_active IP Right Cessation
- 1985-12-09 CS CS859016A patent/CS262425B2/cs not_active IP Right Cessation
- 1985-12-16 NZ NZ214565A patent/NZ214565A/xx unknown
- 1985-12-16 IL IL77338A patent/IL77338A/xx not_active IP Right Cessation
- 1985-12-16 AU AU51259/85A patent/AU583569B2/en not_active Expired
- 1985-12-17 DE DE8585116096T patent/DE3584829D1/de not_active Expired - Lifetime
- 1985-12-17 EP EP85116096A patent/EP0185359B1/de not_active Expired - Lifetime
- 1985-12-17 AT AT85116096T patent/ATE70061T1/de not_active IP Right Cessation
- 1985-12-18 MC MC851814A patent/MC1728A1/fr unknown
- 1985-12-18 PH PH33205A patent/PH26291A/en unknown
- 1985-12-18 HU HU854832A patent/HU200172B/hu unknown
- 1985-12-19 CN CN85108888A patent/CN1012643B/zh not_active Expired
- 1985-12-20 PT PT81748A patent/PT81748B/pt unknown
- 1985-12-20 IE IE327785A patent/IE58926B1/en not_active IP Right Cessation
- 1985-12-20 DK DK600385A patent/DK166724B1/da not_active IP Right Cessation
- 1985-12-20 NO NO855213A patent/NO171160C/no not_active IP Right Cessation
- 1985-12-30 DO DO1985004386A patent/DOP1985004386A/es unknown
-
1987
- 1987-12-17 US US07/134,322 patent/US4931463A/en not_active Expired - Lifetime
-
1990
- 1990-03-19 US US07/495,809 patent/US5175186A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI854797A0 (fi) | 1985-12-04 |
| CN1012643B (zh) | 1991-05-22 |
| PT81748B (pt) | 1988-07-29 |
| AU5125985A (en) | 1986-06-26 |
| MC1728A1 (fr) | 1986-12-15 |
| FI91403B (fi) | 1994-03-15 |
| AU583569B2 (en) | 1989-05-04 |
| HUT39440A (en) | 1986-09-29 |
| NO171160B (no) | 1992-10-26 |
| PT81748A (en) | 1986-01-02 |
| CN85108888A (zh) | 1986-07-09 |
| IL77338A (en) | 1991-04-15 |
| HU200172B (en) | 1990-04-28 |
| US5175186A (en) | 1992-12-29 |
| DOP1985004386A (es) | 1991-04-20 |
| DK600385D0 (da) | 1985-12-20 |
| IE58926B1 (en) | 1993-12-01 |
| PH26291A (en) | 1992-04-10 |
| EP0185359A2 (de) | 1986-06-25 |
| FI854797A7 (fi) | 1986-06-22 |
| DK166724B1 (da) | 1993-07-05 |
| EP0185359B1 (de) | 1991-12-04 |
| ZW20385A1 (en) | 1986-03-05 |
| NO855213L (no) | 1986-06-23 |
| NZ214565A (en) | 1989-06-28 |
| DE3584829D1 (de) | 1992-01-16 |
| CA1270837A (en) | 1990-06-26 |
| DK600385A (da) | 1986-06-22 |
| IE853277L (en) | 1986-06-21 |
| EP0185359A3 (en) | 1987-08-26 |
| FI91403C (fi) | 1994-06-27 |
| US4931463A (en) | 1990-06-05 |
| CS262425B2 (en) | 1989-03-14 |
| ATE70061T1 (de) | 1991-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO171160C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-hydroksyetyl)-2-oksetanonderivater | |
| DK0390456T3 (da) | Oralt anti-sensitivitets-hygiejnepræparat | |
| IE873355L (en) | N-substituted carboxamides | |
| ES2170767T3 (es) | Inhibicion de los sintomas del sindrome premenstrual/trastorno disforico en fase lutea tardia. | |
| IE791004L (en) | 1-phenyl-2-aminoethanol derivatives | |
| GB1321701A (en) | Amino-alcohols their salts and process for prepairing the same | |
| DE19575040I2 (de) | 2-Beta-morpholino androstanderivate und Verfahren zu ihrer Herstellung | |
| DE69615984D1 (de) | Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen | |
| ES9100003A1 (es) | Un procedimiento para la preparacion de oxetanonas. | |
| FR2362127A1 (fr) | Acides dihydro-oxo-nicotiniques, leur preparation et leur application en therapeutique | |
| MY111474A (en) | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders. | |
| FI862251A0 (fi) | Spiro-imidazolidiner som inhibitorer foer aldosreduktas. | |
| DK0533210T3 (da) | Protein C-holdige farmaceutiske præparater som midler mod inflammation. | |
| ES454888A1 (es) | Un procedimiento para la preparacion de nuevos cromados. | |
| GB1549213A (en) | Inflammation inhibitor for cosmetic preparations | |
| IE800900L (en) | Pyrrolidinyl-benzoic acid derivatives. | |
| FR2372816A1 (fr) | Benzisothiazolones et medicaments contenant ces substances | |
| DE59107999D1 (de) | Neue Imidazolverbindungen, Verfahren zu deren Herstellung, Arzneimittel auf Basis dieser Verbindungen sowie einige Zwischenprodukte | |
| FR2280364A1 (fr) | Nouveaux derives de l'acide phenylacetique, leur preparation et les medicaments qui en contiennent | |
| FR2274283A1 (fr) | Nouveau sel de vincamine | |
| FR2080551A2 (en) | Polar-substd. phenyl propanolamines - useful in treatment of cardiac disorders and hypertension | |
| NL7805970A (en) | (N)-Acylated thiazolidine carboxylic acid derivs. - and thiazane and morpholine analogues, useful as antihypertensives | |
| FR2413381A1 (fr) | Derives de thiazolidinedione et leur application en therapeutique | |
| IT8619931A1 (it) | Procedimento per la preparazione della 1-(N-metilamidino)-3-{2,6-dimetilfenil)urea e dei suoi sali farmaceuticamente accettabili | |
| IT228225Y1 (it) | Siringa monouso per iniezione di soluzioni anestetiche odontoiatriche contenute in cartuccia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |